What financial penalty will CVS face in DOJ lawsuit by end of 2025?
No penalty • 25%
Under $1 billion • 25%
$1 billion to $5 billion • 25%
Over $5 billion • 25%
Court documents or DOJ announcements detailing penalties
DOJ Sues CVS for Unlawful Dispensing of Opioids Since Oct. 17, 2013, Across 9,000 Pharmacies
Dec 19, 2024, 04:20 AM
The U.S. Department of Justice has filed a civil lawsuit against CVS Health Corp., alleging that the company knowingly dispensed controlled substances, including opioids, in violation of the federal Controlled Substances Act. The lawsuit claims that CVS filled prescriptions for dangerous and excessive quantities of opioids, as well as 'trinity' prescriptions, a combination of an opioid, a benzodiazepine, and a muscle relaxant, from October 17, 2013, to the present. The DOJ accuses CVS of ignoring substantial evidence from its own pharmacists and internal data that indicated the dispensing of unlawful prescriptions. The complaint also alleges that CVS sought reimbursement from federal health care programs for these prescriptions, violating the False Claims Act. CVS, which operates over 9,000 pharmacies across the U.S., has stated that it has cooperated with the DOJ's investigation for over four years and strongly disagrees with the allegations, describing them as a 'false narrative.'
View original story
No penalty • 25%
Less than $500 million • 25%
$500 million to $1 billion • 25%
Over $1 billion • 25%
Less than $500 million • 25%
More than $2 billion • 25%
$500 million to $1 billion • 25%
$1 billion to $2 billion • 25%
$1 billion to $5 billion • 25%
Less than $1 billion • 25%
No penalty • 25%
More than $5 billion • 25%
No significant impact • 25%
Major financial penalties • 25%
Severe financial penalties • 25%
Minor financial penalties • 25%
Settlement reached • 25%
Case dismissed • 25%
CVS not found liable • 25%
CVS found liable • 25%
CVS found liable • 25%
Case dismissed • 25%
CVS not liable • 25%
CVS settles • 25%
Case dismissed • 25%
Walgreens wins • 25%
DOJ wins • 25%
Settlement reached • 25%
Case dismissed • 25%
Other outcome • 25%
CVS found guilty • 25%
Ongoing litigation • 25%
CVS found liable • 25%
CVS settles • 25%